Browse our comprehensive collection of market intelligence reports.
Adrenocortical carcinoma Pipeline Analysis 2018 – Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Developments.Adrenocortical carcinoma Pipeline Analysis report covers drugs of 11 companies currently in different phases of development. Adrenal cortical carcinoma (ACC) or Adrenocortical carcinoma is a rare disease which is caused by the cancerous growth
Pemphigus Vulgaris (PV) Pipeline Analysis report covers 8 drugs currently in different phases of development. Pemphigus Vulgaris is a rare, autoimmune disorder characterized by painful blistering of the skin and mucous membranes. Organs generally affected by the disease are mouth, eyes, nose, throat, lungs, and genitals. Symptoms include the painful blisters on the skin or mouth along with the oozing, crusting, or peeling at the blister site. The disease is caused when the immune system mista
Primary biliary cirrhosis Pipeline Analysis 2018 – Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Developments.Primary biliary cirrhosis Pipeline Analysis report covers more than 10 drugs currently in different phases of development. Primary biliary cirrhosis is also known as primary biliary cholangitis is a disease which develops slowly and destroys
Graft versus Host Disease (GvHD) Pipeline Analysis report covers 55 drugs currently in different phases of development. GvHD arises as the immune mediated disoder when after receiving the transplant, graft reacts against the host cells. In GvHD donated graft (bone marrow or peripheral blood stem cells) view the recipient’s body as foreign, and the donated cells/bone marrow attack the body. GvHD is classified into two types: Acute GvHD and Chronic GvHD. Symptoms of
Chronic Inflammatory Demyelinating Polyneuropathy Pipeline Analysis 2018 – Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Developments.Chronic Inflammatory Demyelinating Polyneuropathy Pipeline Analysis report covers drugs of 8 companies currently in different phases of development. Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is a neurolo
Adrenomyeloneuropathy (AMN) pipeline analysis report covers more than 10 drugs currently in different phases of development. Adrenomyeloneuropathy is a genetic neurodegenerative disease caused by the mutation of ABCD1 gene. This gene makes the adrenoleukodystrophy protein (ALDP) which helps in the transport of certain types of fats in to peroxisomes. It is a form of X-linked adrenoleukodystrophy and it is also adult onset of adrenoleukodystrophy (
Inclusion Body Myositis Pipeline Analysis 2018 – Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Developments. Inclusion Body Myositis Pipeline Analysis report covers drugs of 3 companies currently in different phases of development. Inclusion Body Myositis (IBM) is one of the inflammatory muscle diseases which involve muscle inflammation and the inflammation of the associated tissues. This includes the blood vessels which
Immune Thrombocytopenic Purpura Pipeline Analysis 2018 – Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Developments. Immune Thrombocytopenic Purpura Pipeline Analysis report covers more than 10 drugs currently in different phases of development. Immune thrombocytopenic purpura (ITP), is also called as Idiopathic thrombocytopenic purpura is a disease which leads to excessive bleeding and also results in the development of
Bronchopulmonary Dysplasia Pipeline Analysis 2018 – Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Developments. Bronchopulmonary Dysplasia (BPD) Analysis report covers 6 drugs currently in different phases of development. Bronchopulmonary Dysplasia (BPD) is a chronic respiratory disease affecting preature newborns and infants. BPD generally occurs in severely ill infants eho have been on ventilator or have received
Focal Segmental Glomerulosclerosis (FSGS) Pipeline Analysis 2018 – Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Developments. Focal Segmental Glomerulosclerosis (FSGS) Analysis report covers 15 drugs currently in different phases of development. FSGS causes the formation of scar tissue in the glomerulus of the kidney. Glomerulus serves as the filtering unit of the kidney. The disease is characterised by asymptomatic prot
Achromatopsia Pipeline Analysis 2018 – Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Developments. Achromatopsia Analysis report covers 3 drugs currently in different phases of development. Achromatopsia is an inherited autosomal recessive disorder characterised by partial or total absence of coloured vision and is also characterised with decreased vision, light sensitivity, and nystagmus (involuntary back-and-forth eye m
Thalassemia Pipeline Analysis report covers more than 18 drugs currently in different phases of development. Thalassemia is an inherited blood disorder disease in which body makes abnormal hemoglobin. Hemoglobin consist of two protein subunits alfa and beta, if there is any mutation in the genes of these protein subunits leads to thalassemia. The disorder result in large number RBC being destroyed which leads to anemia. There are two main types of thalassemia: Alfa thalassemia and Beta t